Taysha Gene Therapies Inc (TSHA)

Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	5.49	-	1.99
	8.88%47.35	43.49	33.79	34.02	28.74
Research and Development	14.28%38.64	33.81	24.95	25.75	20.14
Operating Income/Loss	8.88%-47.35	-43.49	-28.30	-34.02	-26.75
Nonoperating Income/Loss	34.01%0.71	1.08	0.45	1.29	-0.13
Income Tax Expense/Benefit	-	-	-	-	-
	9.97%-46.64	-42.41	-27.85	-32.73	-26.88
Attributable To Parent	9.97%-46.64	-42.41	-27.85	-32.73	-26.88
Available To Common Stockholders, Basic	9.97%-46.64	-42.41	-27.85	-32.73	-26.88
Basic Average Shares	0.66%369.04	366.63	-	353.31	297.99
Diluted Average Shares	0.66%369.04	366.63	-	353.31	297.99
Basic Earnings Per Share	8.33%-0.13	-0.12	-	-0.09	-0.09
Diluted Earnings Per Share	8.33%-0.13	-0.12	-	-0.09	-0.09